Piaggio E - Search Results

1

Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.

Ramos RN, Tosch C, Kotsias F, Claudepierre MC, Schmitt D, Remy-Ziller C, Hoffmann C, Ricordel M, Nourtier V, Farine I, Laruelle L, Hortelano J, Spring-Giusti C, Sedlik C, Le Tourneau C, Hoffmann C, Silvestre N, Erbs P, Bendjama K, Thioudellet C, Quemeneur E, Piaggio E, Rittner K. Ramos RN, et al. Among authors: piaggio e. Clin Transl Immunology. 2022 May 8;11(5):e1392. doi: 10.1002/cti2.1392. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35573979 Free PMC article.

2

Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.

Lobón-Iglesias MJ, Andrianteranagna M, Han ZY, Chauvin C, Masliah-Planchon J, Manriquez V, Tauziede-Espariat A, Turczynski S, Bouarich-Bourimi R, Frah M, Dufour C, Blauwblomme T, Cardoen L, Pierron G, Maillot L, Guillemot D, Reynaud S, Bourneix C, Pouponnot C, Surdez D, Bohec M, Baulande S, Delattre O, Piaggio E, Ayrault O, Waterfall JJ, Servant N, Beccaria K, Dangouloff-Ros V, Bourdeaut F. Lobón-Iglesias MJ, et al. Among authors: piaggio e. Nat Commun. 2023 Oct 20;14(1):6669. doi: 10.1038/s41467-023-42371-7. Nat Commun. 2023. PMID: 37863903 Free PMC article.

3

Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.

Knittel D, Gadzinski A, Hua S, Denizeau J, Savatier A, de la Rochère P, Boulain JC, Amigorena S, Piaggio E, Sedlik C, Léonetti M. Knittel D, et al. Among authors: piaggio e. Vaccine. 2016 Jun 8;34(27):3093-3101. doi: 10.1016/j.vaccine.2016.04.073. Epub 2016 May 4. Vaccine. 2016. PMID: 27154391

4

Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen.

Sedlik C, Heitzmann A, Viel S, Ait Sarkouh R, Batisse C, Schmidt F, De La Rochere P, Amzallag N, Osinaga E, Oppezzo P, Pritsch O, Sastre-Garau X, Hubert P, Amigorena S, Piaggio E. Sedlik C, et al. Among authors: piaggio e. Oncoimmunology. 2016 Apr 22;5(7):e1171434. doi: 10.1080/2162402X.2016.1171434. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622021 Free PMC article.

5

Mechanisms of Resistance to Immune Checkpoint Antibodies.

Ramos RN, Piaggio E, Romano E. Ramos RN, et al. Among authors: piaggio e. Handb Exp Pharmacol. 2018;249:109-128. doi: 10.1007/164_2017_11. Handb Exp Pharmacol. 2018. PMID: 28315073 Review.

6

CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8⁺ T Cells.

Canale FP, Ramello MC, Núñez N, Araujo Furlan CL, Bossio SN, Gorosito Serrán M, Tosello Boari J, Del Castillo A, Ledesma M, Sedlik C, Piaggio E, Gruppi A, Acosta Rodríguez EA, Montes CL. Canale FP, et al. Among authors: piaggio e. Cancer Res. 2018 Jan 1;78(1):115-128. doi: 10.1158/0008-5472.CAN-16-2684. Epub 2017 Oct 24. Cancer Res. 2018. PMID: 29066514

7

Induction of anergic or regulatory tumor-specific CD4⁺ T cells in the tumor-draining lymph node.

Alonso R, Flament H, Lemoine S, Sedlik C, Bottasso E, Péguillet I, Prémel V, Denizeau J, Salou M, Darbois A, Núñez NG, Salomon B, Gross D, Piaggio E, Lantz O. Alonso R, et al. Among authors: piaggio e. Nat Commun. 2018 May 29;9(1):2113. doi: 10.1038/s41467-018-04524-x. Nat Commun. 2018. PMID: 29844317 Free PMC article.

8

CD16⁺NKG2A^high Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes.

Frazao A, Messaoudene M, Nunez N, Dulphy N, Roussin F, Sedlik C, Zitvogel L, Piaggio E, Toubert A, Caignard A. Frazao A, et al. Among authors: piaggio e. Cancer Immunol Res. 2019 Feb;7(2):208-218. doi: 10.1158/2326-6066.CIR-18-0085. Epub 2018 Dec 4. Cancer Immunol Res. 2019. PMID: 30514793

9

IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation.

Caudana P, Núñez NG, De La Rochere P, Pinto A, Denizeau J, Alonso R, Niborski LL, Lantz O, Sedlik C, Piaggio E. Caudana P, et al. Among authors: piaggio e. Cancer Immunol Res. 2019 Mar;7(3):443-457. doi: 10.1158/2326-6066.CIR-18-0697. Epub 2019 Jan 16. Cancer Immunol Res. 2019. PMID: 30651291

10

TLR3 Activation of Intratumoral CD103⁺ Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity.

Roselli E, Araya P, Núñez NG, Gatti G, Graziano F, Sedlik C, Benaroch P, Piaggio E, Maccioni M. Roselli E, et al. Among authors: piaggio e. Front Immunol. 2019 Mar 20;10:503. doi: 10.3389/fimmu.2019.00503. eCollection 2019. Front Immunol. 2019. PMID: 30949170 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page